Tenax Therapeutics (TENX) EBT Margin (2010 - 2015)
Tenax Therapeutics recorded quarterly EBT Margin of 9877.81% in Q2 2015, down 862.97% quarter-over-quarter from 1025.76% in Q2 2013.
Tenax Therapeutics' EBT Margin history runs 5 years deep, the most recent figure standing at 9877.81% for Q2 2015.
- In Q2 2015, EBT Margin changed N/A year-over-year to 9877.81%; the TTM figure through Jun 2016 stood at 29552.48% (down 2844628.0% YoY), while the FY2015 annual figure was 6953.21%, changed N/A from the prior year.
- EBT Margin came in at 9877.81% for Q2 2015 at Tenax Therapeutics, down from 1025.76% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 10522.58% in Q1 2011 to a low of 11513.99% in Q3 2011.
- A 4-year average of 1737.37% and a median of 1323.56% in 2012 frame the typical range for EBT Margin.
- On a YoY basis, EBT Margin climbed as much as 1019043 bps in 2012 and fell as far as 1546146 bps in 2012.
- Tenax Therapeutics' EBT Margin stood at 3074.85% in 2011, then soared by 90 bps to 301.12% in 2012, then plunged by 241 bps to 1025.76% in 2013, then slumped by 863 bps to 9877.81% in 2015.
- According to Business Quant data, EBT Margin over the past three periods registered 9877.81%, 1025.76%, and 1091.73% for Q2 2015, Q2 2013, and Q1 2013 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -9,877.81% |
| Apr 30, 2013 | -1,025.76% |
| Jan 31, 2013 | -1,091.73% |
| Oct 31, 2012 | -301.12% |
| Jul 31, 2012 | -1,323.56% |
| Apr 30, 2012 | -2,912.96% |
| Jan 31, 2012 | -4,938.89% |
| Oct 31, 2011 | -3,074.85% |
| Jul 31, 2011 | -11,513.99% |
| Apr 30, 2011 | 6,427.01% |
| Jan 31, 2011 | 10,522.58% |
| Oct 31, 2010 | 7,562.32% |